Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Diebold Nixdorf Incorporated is a software-application business based in the US. Diebold Nixdorf Incorporated shares (DBD) are listed on the NYSE and all prices are listed in US Dollars. Diebold Nixdorf Incorporated employs 22,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.52|
|52-week range||$5.97 - $17.30|
|50-day moving average||$10.32|
|200-day moving average||$12.20|
|Wall St. target price||$17.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.45|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.66%|
|1 month (2021-09-18)||N/A|
|3 months (2021-07-22)||-6.32%|
|6 months (2021-04-22)||-22.87%|
|1 year (2020-10-22)||33.50%|
|2 years (2019-10-22)||10.74%|
|3 years (2018-10-22)||169.05%|
|5 years (2016-10-21)||22.25|
Valuing Diebold Nixdorf Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Diebold Nixdorf Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Diebold Nixdorf Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.52. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Diebold Nixdorf Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Diebold Nixdorf Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $319.4 million.
The EBITDA is a measure of a Diebold Nixdorf Incorporated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4 billion|
|Operating margin TTM||4.54%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||3.12%|
|Return on equity TTM||-9999999%|
|Market capitalisation||$841.5 million|
TTM: trailing 12 months
There are currently 6.6 million Diebold Nixdorf Incorporated shares held short by investors – that's known as Diebold Nixdorf Incorporated's "short interest". This figure is 4.7% down from 7.0 million last month.
There are a few different ways that this level of interest in shorting Diebold Nixdorf Incorporated shares can be evaluated.
Diebold Nixdorf Incorporated's "short interest ratio" (SIR) is the quantity of Diebold Nixdorf Incorporated shares currently shorted divided by the average quantity of Diebold Nixdorf Incorporated shares traded daily (recently around 532785.03620274). Diebold Nixdorf Incorporated's SIR currently stands at 12.43. In other words for every 100,000 Diebold Nixdorf Incorporated shares traded daily on the market, roughly 12430 shares are currently held short.
However Diebold Nixdorf Incorporated's short interest can also be evaluated against the total number of Diebold Nixdorf Incorporated shares, or, against the total number of tradable Diebold Nixdorf Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Diebold Nixdorf Incorporated's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Diebold Nixdorf Incorporated shares in existence, roughly 80 shares are currently held short) or 0.0974% of the tradable shares (for every 100,000 tradable Diebold Nixdorf Incorporated shares, roughly 97 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Diebold Nixdorf Incorporated.
Find out more about how you can short Diebold Nixdorf Incorporated stock.
We're not expecting Diebold Nixdorf Incorporated to pay a dividend over the next 12 months.
Diebold Nixdorf Incorporated's shares were split on a 3:2 basis on 19 February 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Diebold Nixdorf Incorporated shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Diebold Nixdorf Incorporated shares which in turn could have impacted Diebold Nixdorf Incorporated's share price.
Over the last 12 months, Diebold Nixdorf Incorporated's shares have ranged in value from as little as $5.97 up to $17.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Diebold Nixdorf Incorporated's is 3.2614. This would suggest that Diebold Nixdorf Incorporated's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America. The company operates through Eurasia Banking, Americas Banking, and Retail segments. It offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics. It also provides banking product-related services comprising proactive monitoring and rapid resolution of incidents through remote service capabilities or an on-site visit; first and second line maintenance, and preventive maintenance and on-demand services; managed and outsourcing services, such as business processes, solution management, upgrades and transaction processing; and cash management services. In addition, the company offers DN Vynamic software suite; mobile point of sale and self-checkout terminals; printers, scales, and mobile scanners; and banknote and coin processing systems. Additionally, it provides retail customer's product-related services, such as on-demand and professional services; maintenance and availability services; implementation services; managed mobility services; monitoring and advanced analytics; and store life-cycle management services. Diebold Nixdorf, Incorporated has strategic relationship with Accenture.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.